SGMS2 and metastatic malignant neoplasm in the lymph nodes: However, it was intriguing that the expression of SGMS2 was higher in patients with lymph node metastasis than in those without metastasis, which strongly suggests that SGMS2 is associated with tumour metastasis in breast cancer patients.